Purpose The objective of this study was to evaluate the efficiency of vitrified blastocysts derived from frozenthawed cleavage stage embryos in terms of morphological survival and re-expansion status of the blastocoelic cavity. Results After warming 162 blastocysts derived from fresh embryos (= control group) and 90 blastocysts from frozenthawed cleavage stage embryos (= study group) and after 2-3 h of in vitro culture the percentage of blastocysts with morphological survival was not different between the two groups. After 24 h of in vitro culture, the percentage of fully expanded, hatching or hatched blastocysts was not different between both groups.
Introduction
The objective of IVF should be to provide couples with a single healthy baby per transfer and if possible more than one healthy baby per treatment cycle. To accomplish this goal single embryo transfer (SET) is becoming an increasingly accepted procedure [1] . A consequence of SET is an increase in the number of embryos available for cryopreservation and optimized cryopreservation after SET should be part of the strategy to decrease multiple pregnancies [1, 2] . Human embryos have been cryopreserved at the two pronuclear stages, at different multicellular cleavage stages or at the blastocyst stage using different slow-controlled-rate freezing and/or vitrification protocols. Although slow freezing procedures are still an option, vitrification appears to have better results for post-warming survival and for pregnancy rates [3] . In our centre, human embryos were frozen using a slowcontrolled rate freezing procedure with 1,2-propanediol as cryoprotectant. Up to two embryos were frozen per straw. Consequently after thawing and overnight culture more than one good-quality embryo might be available for transfer. Therefore, in order to avoid double embryo transfer and the occurrence of multiple pregnancy, recryopreservation procedures at the blastocyst stage could be considered. So far, limited data has been published with human embryos that were frozen-thawed twice and the documentation on successful live births derived from re-frozen embryos or blastocysts is mostly limited to case reports [4] [5] [6] [7] [8] [9] [10] [11] . Sheehan et al. [12] demonstrated in a mouse model that vitrification methods allowed multiple cryopreservations with minimal damage.
The papers of Kumasako et al., [11] , Valle et al. [13] and Stanger et al. [14] described that embryos and blastocysts that had been frozen once either with slow-freezing or vitrification can be re-frozen by vitrification on day 3 or day 5/6.
The aim of our study was to evaluate the efficiency of recryopreservation by vitrification of day 6 blastocysts derived from slow-controlled-rate frozen and thawed cleavage stage human day 2/3 embryos.
Materials and methods

Source of embryos
Embryos for research were obtained after informed consent of the patients. The research was approved by the Federal Ethical committee (approval Adv027) and local Ethical Committee (approval 2009/660).
Embryos included in the study were either fresh or frozen-thawed spare embryos obtained in our IVF programme. They were spare embryos because they were of insufficient quality to be used for patient treatment. Insufficient quality was defined as embryos with high fragmentation (≥ 25 %) on day 2 or day 3 of development, and (or) multinucleated blastomeres on day 2, and (or) delayed development (< 5 blastomeres on day 3 or a≤1 blastomere increase from day 2 to 3). These embryos will be further referred to as poor quality embryos. The embryos were further cultured up to day 6 and used for the study when they reached at least the expanded blastocyst stage. Expanded blastocysts were then vitrified and as a result two groups of expanded vitrified blastocysts could be identified: (1) vitrified expanded blastocysts derived from non-frozen poor quality cleavage-stage embryos (once cryopreserved=control group) and (2) vitrified expanded blastocysts derived from slow controlled-rate frozen and thawed poor-quality cleavage-stage embryos (twice cryopreserved=study group).
Embryo culture and scoring of blastocysts
Before vitrification at the expanded blastocyst stage, poor quality non-frozen or frozen thawed cleavage-stage embryos were cultured in vitro in COOK media formulations (Cook Ireland Ltd., Limerick, Ireland).
Before vitrification, the quality of the trophectoderm (TE) and the inner cell mass (ICM) cells in the expanded blastocysts was evaluated according to the scoring system described by Stephenson [15] . Briefly, ICM grades A and B are given to large and distinct ICMs, with grade A being more compact and B having larger, less compact cells. Grade C is used for small ICMs, grade D for degenerating ICMs, and grade E when no apparent ICM is visible. For the scoring of the trophectoderm, grades A, B, or C correspond to good, moderate and poor quality respectively. Blastocyst expansion was scored from 1 (no expansion of overall size) to 6 (fully hatched from zona pellucida).
Blastocysts with minimal grade C trophectoderm and grade C inner cell mass were vitrified.
Blastocysts with a minimal grade B trophectoderm and grade B inner cell mass were considered as good-quality blastocyst.
Artificial shrinkage of expanded blastocyst
All expanded blastocysts were vitrified after initial artificial shrinkage (AS) of the blastocoele cavity by means of mechanical pipetting. Briefly, the expanded blastocyst was aspirated through a glass pipette which was slightly smaller in diameter than the diameter of the expanded blastocyst. After confirmation of initial shrinkage of the blastocoele, pipetting was performed with a pipette slightly smaller in diameter than the first one. This procedure was repeated two or three times until the blastocoele collapsed completely.
Vitrification of blastocysts
The vitrification procedure was done according to Kuwayama et al. [16] with some modifications. Briefly, all media were pre-warmed at 37°C, and all vitrification and warming steps were done on a warm plate set at 37°C.
Expanded blastocysts collapsed after AS were equilibrated for 2 min in equilibration medium consisting of Hepesbuffered medium supplemented with 20 % v/v human serum albumin (HSA, Rode Kruis, Belgium) and also containing 7.5 % v/v ethylene glycol (Sigma, Bornem) and 7.5 % v/v dimethylsulfoxide (Sigma). The blastocysts were then transferred to the vitrification solution, consisting of Hepesbuffered medium with HSA and also containing 15 % v/v ethylene glycol and 15 % v/v dimethylsulfoxide and 0.5 M sucrose and after 45 to 60 s loaded onto a CBS-HS vitrification straw (Cryo BioSystem,I.M.V. Technologies) in a very small volume. After sealing, the straws were immediately plunged into liquid nitrogen (LN 2 ).
The total time required for loading, sealing, and plunging did not exceed the 30 s.
For warming, the CBS-HS straw was first transferred from the LN 2 into a 37°C warm Hepes-buffered medium also containing 1 M sucrose. The warmed blastocysts were then immediately transferred into a new drop of 37°C warm 1 M sucrose in Hepes-buffered medium supplemented with HSA and further incubated for 1 min. After that, the blastocysts were consecutively transferred for 3 min to a dilution solution of 37°C warm 0.5 M sucrose in Hepes-buffered medium supplemented with HSA and for 5 min to 37°C warm Hepes-buffered medium plus HSA. Warmed blastocysts were then incubated for 24 h in Cook Blastocyst medium and assessed for in vitro survival.
Assessment of survival
Main outcome measures were the survival rates of the blastocysts after warming and further in vitro culture for 2-3 h and 24 h. At the two different time points the blastocysts were examined under an inverted microscope at×400 magnification, and morphological survival rate was assessed based on the morphological integrity of the ICM and TE (fully intact and moderately damaged). After 24 h of in vitro culture survival rate was also assessed as the capability of warmed blastocysts to expand or re-expand.
Statistics
Statistic analyses was performed using the Instat V 2.0 software package (Graph Pad Software, San Diego, CA, USA) and SPSS version 19 (SPSS software, Chicago, IL, USA)
Percentages of survival rate, developmental capacity were compared by contingency table analysis followed by chisquare subtests. The Mann-Whitney U-test was used to analyse the distribution of the different qualities of blastocysts vitrified in study and control group.
When P was<0.05, the difference was considered to be significant.
Results
During the study period 162 blastocysts were vitrified in the once cryopreserved control group and 90 blastocysts were vitrified in the twice cryopreserved study group. The distribution of the different qualities (ICM and TE) of the expanded blastocysts vitrified in both groups, is presented in Table 1 . There was no difference in the distribution of the different qualities of expanded blastocysts vitrified between both groups (Mann-Whitney U-Test, P=0.12). In both groups expanded blastocysts with at least grade B ICM and grade B TE were considered as good-quality blastocysts.
The percentage of blastocysts with morphological survival after 2-3 h and 24 h was not different between the twice cryopreserved study group Table 2 ). In the study group of twice cryopreserved blastocysts, the blastocysts were derived from a mixture of frozen cleavage-stage embryos that were either fully intact or had more than 50 % intact blastomeres after thawing. After 24 h culture, vitrified and warmed blastocysts derived from fully intact frozen cleavage stage embryos after thawing had a morphological survival rate of 71.2 % (37/52) which was comparable to 60.5 % (23/38) for vitrified and warmed blastocysts derived from non-fully intact frozen and thawed cleavage-stage embryos (data not show in Table 2 ).
After 24 h of in vitro culture, the expansion/hatching status of the surviving blastocysts was evaluated. The results are presented in Table 3 (*) These blastocysts were considered as good-quality blastocyst
There was no significant difference in the distribution of the different qualities of expanded blastocysts vitrified between both groups (MannWhitney U-Test, P=0.12) better technique for the cryopreservation of reproductive cells as compared to slow-controlled-rate freezing [3, 17] . Therefore in the present study we vitrified expanded blastocysts with a minimal grade C trophectoderm and grade C inner cell mass. For clinical purposes blastocyst morphology before cryopreservation is an important tool, because the quality of the blastocyst will have a significant impact on survival rate. It is known that the efficiency of the vitrification method depends on the expansion status of the blastocyst, with better survival rates at morula or early blastocyst stages compared to full or expanded blastocysts [18, 19] . Therefore as suggested by Vanderzwalmen et al. [18, 19] in the present study we artificially collapsed the blastocyst to minimize the cavity volume. The capacity to vitrify and warm expanded artificially collapsed blastocysts that have already been cryopreserved at the cleavage-stage demonstrate that vitrification causes minimal cryo injury. Minimal morphological damage is observed and in terms of viability by retaining the capacity to expand and re-expand after further culture in vitro. The results of our study demonstrate the feasibility of vitrification of expanded human blastocysts obtained from slow-controlled rate frozen and thawed cleavage-stage embryos. The morphological survival of these vitrified expanded blastocysts, which are cryopreserved twice, and their developmental potential after 24 h of further culture in vitro was not different from vitrified human blastocysts that were derived from cleavage stage embryos that has been cryopreserved once. The results obtained indicate that vitrification at the expanded blastocyst stage may be an efficient method for cleavage-stage embryo freezing and subsequent re-cryopreservation after thawing. In literature, there have been case reports and papers detailing on the re-cryopreservation by either slow-freezing and slowrefreezing, slow freezing and re-vitrification, vitrification and re-vitrification involving several species and at different developmental stages, [12] [13] [14] [20] [21] [22] [23] [24] [25] [26] [27] [28] [14] . Of course, we do not know the in vivo implantation potential of these blastocysts but the promising results on the morphological survival and re-expansion of these blastocysts may have an important implication for the practical management of infertility cases where cleavage stage freezing has been or still is considered. In general, further in vitro culture to the expanded blastocyst stage allows us to select those embryos with the highest implantation potential. When patients return for a cryopreserved embryo transfer, they may elect to have individual cleavage stage embryos frozen, thawed and transferred over multiple cycles or to thaw multiple embryos. When thawing multiple embryos as is inevitably the case when more than one embryo is frozen per straw, several surviving (fully intact and partially intact) cleavage stage embryos may co-exist. From literature we know that partially intact thawed cleavage stage embryo's can result in pregnancies, but that the implantation potential drops in parallel with increasing degrees of blastomere lysis [29] [30] [31] . Our study supports the idea of extending culture of surviving cleavage-stage embryos up to the blastocyst stage, in order to help to identify the best embryo for transfer. Since our study indicates that vitrification of expanded blastocysts obtained from slow-controlled-rate frozen and thawed cleavage stage embryos is a validated and robust procedure, the advantage in thawing many embryos and extending their culture is that it allows the patient to maximize their chance of pregnancy in a shorter time period .
In conclusion, our results show that blastocysts derived from frozen-thawed cleaved-stage embryos can successfully be cryopreserved a second time by vitrification. The cryopreservation by vitrification could be a valuable option to increase the cumulative pregnancy rate while decreasing the risk of multiple gestations, but still needs to be approached with some caution because little data is available on the long term safety of multiple cryopreservations.
